Mycobacterial and Other Serious Infections in Patients Receiving Anti-tumor Necrosis Factor and Other Newly Approved Biologic Therapies: Case Finding Through the Emerging Infections Network

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2008 Apr 19

PMID 18419421

Citations 50

Authors

Kevin L Winthrop

S Yamashita

S E Beekmann

P M Polgreen

Affiliations

Soon will be listed here.

Abstract

We present the results of a nationwide survey of infectious disease consultants to identify mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor compounds and other novel targeted therapies. Nontuberculous mycobacterial infections, histoplasmosis, and invasive Staphylococcus aureus infection were all reported more frequently than was tuberculosis disease in this context.

Citing Articles

Clinical course of nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis.

Kwak N, Moon J, Kim J, Park J, Yim J Adv Rheumatol. 2024; 64(1):20.

PMID: 38491558 DOI: 10.1186/s42358-024-00357-z.

A Systemic Lupus Erythematosus Patient with Cutaneous Infection under Belimumab Treatment: A Case Report.

Kim J, Hasegawa T, Tada K, Uehara Y, Fukui Y, Nakamura A Ann Dermatol. 2023; 35(Suppl 1):S63-S66.

PMID: 37853868 PMC: 10608360. DOI: 10.5021/ad.21.077.

Digging into the Histology.

Paknikar R, Alpert L, Cohen R, Shogan B, Micic D N Engl J Med. 2023; 389(14):1321-1326.

PMID: 37792616 PMC: 10699882. DOI: 10.1056/NEJMcps2304154.

: A Case-Based Narrative Review of Diagnosis and Management.

Tsiolakkis G, Liontos A, Filippas-Ntekouan S, Matzaras R, Theodorou E, Vardas M Microorganisms. 2023; 11(7).

PMID: 37512971 PMC: 10384600. DOI: 10.3390/microorganisms11071799.

Global survey of physician testing practices for nontuberculous mycobacteria.

Loebinger M, van der Laan R, Obradovic M, van Ingen J ERJ Open Res. 2023; 9(3).

PMID: 37143838 PMC: 10152245. DOI: 10.1183/23120541.00737-2022.